CAMP4 THERAPEUTICS CORPORATION

Healthcare · Biotechnology

3.80$ +3.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

CAMP4 THERAPEUTICS CORPORATION (CAMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 93 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CAMP
Line item	Q1 14	Q2 14	Q3 14	Q1 15	Q3 15	Q1 16	Q2 16	Q3 16	Q1 17	Q2 17	Q3 17	Q1 18	Q2 18	Q3 18	Q1 19	Q2 19	Q3 19	Q1 20	Q2 20	Q3 20	Q1 21	Q2 21	Q3 21	Q1 22	Q2 22	Q3 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	179	181	198	360	370	426	420	403	427	446	475	493	611	608	652	659	562	480	482	442	421	419	402	375	371	389	380	372	364	55	30	30	21	78	63	51	86	118	105	93
Current Assets	92	96	113	263	290	222	221	207	217	238	272	294	422	419	339	351	253	230	231	215	204	205	194	168	169	183	175	168	166	40	15	15	5.5	66	52	41	78	114	102	90
Cash	19	22	24	116	107	67	95	75	109	127	138	170	274	272	190	194	102	104	107	92	96	101	91	59	48	45	42	35	39	38	13	13	2.5	64	49	39	75	110	99	87
Cash & Short-Term Investments	28	34	37	184	223	118	117	101	109	131	151	179	305	302	200	201	104	104	107	92	96	101	91	59	48	45	42	35	39	38	13	13	2.5	64	49	39	75	110	99	87
Receivables	37	35	45	45	45	69	69	67	66	64	70	70	71	72	74	76	83	67	68	68	64	62	59	66	75	88	83	85	71	0.4	–	0.3	1.1	0.1	0.1	0.1	0.1	0.2	–	0.2
Inventory	15	15	20	16	18	28	28	31	33	31	39	33	31	32	42	50	44	36	31	32	18	17	20	19	22	23	24	24	30	34	–	–	–	–	–	–	–	–	–	–
Goodwill	15	16	15	17	17	67	63	64	73	73	73	73	73	73	103	104	106	101	102	94	95	95	94	94	93	94	94	95	95	21	–	–	–	–	–	–	–	–	–	–
Intangible Assets	29	27	24	22	19	79	75	71	63	60	56	49	46	44	73	69	67	43	41	39	36	35	33	31	29	28	27	26	25	24	–	–	–	–	–	–	–	–	–	–
Total Liabilities	46	44	55	187	189	237	239	234	253	260	274	291	401	406	453	466	372	355	363	343	325	329	322	346	349	370	366	360	353	179	15	177	180	15	11	11	28	70	75	94
Current Liabilities	42	39	50	46	45	83	82	74	85	88	98	101	96	98	212	221	130	99	103	107	96	100	95	86	91	108	107	99	96	7.8	7.8	7.8	12	9.6	6.4	7.3	7.9	16	17	19
Short-Term Debt	1.2	1.2	0.6	0.4	6.8	11	11	11	5.7	30	32	31	33	37	123	124	38	5.5	11	11	3.8	3.4	7.7	7.4	1.8	6.0	5.6	5.1	4.8	4.8	3.4	3.1	3.1	3.1	3.1	3.2	3.3	0.3	0.4	0.8
Accounts Payable	21	20	30	26	25	36	37	33	34	35	42	43	36	32	33	40	37	32	31	37	29	31	31	29	40	53	53	48	46	47	1.5	1.5	3.9	1.2	1.4	1.2	1.2	0.2	0.9	1.1
Shareholders' Equity	133	137	144	174	182	189	181	168	174	186	201	202	210	202	199	193	191	125	119	99	96	90	80	29	22	19	14	12	11	-124	15	-147	-159	63	52	40	59	48	31	-0.7
Retained Earnings	-73	-71	-63	-53	-45	-43	-42	-44	-39	-26	-15	-12	-13	-13	-11	-18	-26	-96	-106	-129	-140	-145	-157	-148	-156	-161	-169	-173	-177	-160	-185	-185	-198	-212	-224	-237	-252	-292	-310	-344
Shares Outstanding	36	37	37	37	37	37	37	36	35	36	36	36	35	35	33	34	34	34	34	35	35	35	35	36	36	36	36	37	37	20	12	20	20	20	20	20	20	52	58	58

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings